Effect of glargine insulin on hyperglycemic control in type II diabetic patients
Phase 2
- Conditions
- type II diabetic.Type 2 diabetes mellitus
- Registration Number
- IRCT20130428013159N11
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age of 35-75 years
Sustaining ASA II
Blood sugar of 150-300 mg/dl
Lack of a simultaneous emergency surgery or heart valve surgery.
Exclusion Criteria
Having underlying diseases (e.g., pulmonary, liver, kidney, thyroid, and digestive diseases)
Having history of open-heart surgery
Fever
Trauma
Carotid artery involvement
Sensitivity to insulin glargine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose. Timepoint: Before the surgery, every 2 hours intraoperatively, and every 4-24 hours after the surgery. Method of measurement: Glucose meter.
- Secondary Outcome Measures
Name Time Method